Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -130,685 | -91,754 | -79,676 | -50,159 | -49,073 |
| Depreciation Amortization | 2,589 | 3,664 | 4,596 | 3,628 | 2,438 |
| Income taxes - deferred | N/A | 7,892 | 1,264 | 1,567 | N/A |
| Accounts receivable | 3,410 | -1,841 | -3,681 | -1,975 | -1,770 |
| Accounts payable and accrued liabilities | 13,304 | 6,985 | 8,815 | 194 | -220 |
| Other Working Capital | 17,061 | -5,998 | 13,183 | 10,501 | 60,155 |
| Other Operating Activity | -854 | 1,236 | 2,682 | 9,875 | 7,525 |
| Operating Cash Flow | $-95,175 | $-79,816 | $-52,817 | $-26,369 | $19,055 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -17,823 | -71,785 | N/A | N/A | N/A |
| PPE Investments | -9,857 | -3,189 | -3,754 | -4,999 | -5,038 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 92 |
| Other Investing Activity | -59 | -247 | 7 | 99 | 95 |
| Investing Cash Flow | $-27,739 | $-75,221 | $-3,747 | $-4,900 | $-4,851 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 121,537 | 41,128 | N/A | N/A | N/A |
| Common Stock Issued | 28,752 | 105,452 | 1,745 | 294 | 183 |
| Dividend Paid | -3 | -4,235 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -48 | 74,560 | 3,301 | -974 |
| Financing Cash Flow | $150,286 | $142,297 | $76,305 | $3,595 | $-791 |
| Beginning Cash Position | 37,714 | 50,454 | 30,713 | 58,387 | 44,974 |
| End Cash Position | 65,086 | 37,714 | 50,454 | 30,713 | 58,387 |
| Net Cash Flow | $27,372 | $-12,740 | $19,741 | $-27,674 | $13,413 |
| Free Cash Flow | |||||
| Operating Cash Flow | -95,175 | -79,816 | -52,817 | -26,369 | 19,055 |
| Capital Expenditure | -9,857 | -3,189 | -3,754 | -5,025 | -5,038 |
| Free Cash Flow | -105,032 | -83,005 | -56,571 | -31,394 | 14,017 |